Dizziness / vertigo
This medicine may cause dizziness or vertigo.
Leaflet OLSSA 20mg / 5mg film-coated tablets
- Product code:
- W66702011
- Quantity:
- 28
- Indicated for:
- hypertension
- Route of administration:
- oral
- Substance:
- olmesartan medoxomil + amlodipine (antihypertensive + calcium channel blocker)
- ATC
- C09DB02 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and calcium channel blockers
Precautions:
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Hypotension / fall risk
May lower blood pressure and increase the risk of falls.
Major drug interactions
This medicine may have important interactions with other medicines.
Requires periodic laboratory tests
Periodic laboratory tests may be required during treatment.
Electrolyte disturbances
This medicine may change blood electrolyte levels.
This combination of olmesartan medoxomil and amlodipine is used for the treatment of hypertension in patients not adequately controlled with a single medication. Olmesartan blocks angiotensin II receptors, while amlodipine is a calcium channel blocker that relaxes blood vessels.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, edema, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, edema, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.
Patients should be aware of potential side effects, such as dizziness, edema, or headaches. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, edema, headaches, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about OLSSA 20mg / 5mg
- Substance:
- olmesartan medoxomil + amlodipine
- Date of latest medicines list:
- 01-06-2026
- Product code:
- W66702011
- Concentration:
- 20mg / 5mg
- Pharmaceutical form:
- film-coated tablets
- Quantity:
- 28
- Product type:
- Generic medicine
- Price:
- 55.53 RON
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Concentrations available for olmesartan medoxomil + amlodipine
- 20mg/5mg
- 40mg/10mg
- 40mg/5mg
Compensation lists for OLSSA 20mg / 5mg KRKA
B - Sublist B with 50% discount from the reference price
- Price
- 55.53 RON
- Copayment
- 13.23 RON
- Patient
- 42.30 RON